Hero Image

Ocular Gene Therapy Laboratory

The Ocular Gene Therapy Laboratory (OGTL)

Founded in 2016 by Daniel M. Lipinski, DPhil, the Ocular Gene Therapy (OGT) laboratory aims to develop broadly applicable gene-based therapeutics to prevent human blindness arising from neurodegenerative or vascular diseases affecting the retina. Consisting of faculty, students and staff from a diverse range of academic backgrounds, the OGT laboratory takes a highly multidisciplinary and collaborative approach towards research, working with basic science and clinical investigators worldwide to identify novel therapies for currently untreatable conditions that result in vision loss in humans. Learn More
OGTL Group Image_Intro Component